G. Thomas Budd on Genomic Profiling for Targeted Therapies

Video

G. Thomas Budd, MD, medical oncologist, Taussig Cancer Center at Cleveland Clinic, discusses genomic profiling for targeted therapies.

G. Thomas Budd, MD, medical oncologist, Taussig Cancer Center at Cleveland Clinic, discusses genomic profiling for targeted therapies.

Genomic profiling is not commonly done because of the expense, Budd says, but there is pressure to make the technology more widely available available to patients.

Budd adds that genomic profiling is still being studied in clinical trials. The NCI-MATCH trial, for example, patients will undergo genomic profiling to determine whether they have a genetic mutation or molecular abnormality that will respond to a targeted drug.

Related Videos
MPN-Associated Anemia: What Nurses Should Look Out For
Cancer-Related Cognitive Impairment
Charina Toste
Lindsey Lyle
Alyssa Ridad
Yelena Shames
Johanna Garibaldi
Elizabeth Cullen
Shivani Gopalsami
Related Content
© 2023 MJH Life Sciences

All rights reserved.